Clinicopathological and prognostic characteristics of CD56‐negative multiple myeloma
Open Access
- 10 June 2002
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 117 (4) , 882-885
- https://doi.org/10.1046/j.1365-2141.2002.03513.x
Abstract
The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.Keywords
This publication has 8 references indexed in Scilit:
- Distribution of myeloma plasma cells in peripheral blood and bone marrow correlates with CD56 expressionBritish Journal of Haematology, 1999
- The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myelomaLeukemia, 1998
- Plasmablastic Morphology—An Independent Prognostic Factor With Clinical and Laboratory Correlates: Eastern Cooperative Oncology Group (ECOG) Myeloma Trial E9486 Report by the ECOG Myeloma Laboratory GroupBlood, 1998
- Clinicopathological correlates of CD56 expression in multiple myeloma: a unique entity?British Journal of Haematology, 1995
- Phenotypic difference of normal plasma cells from mature myeloma cellsBlood, 1993
- Plasma cells in multiple myeloma express a natural killer cell- associated antigen: CD56 (NKH-1; Leu-19)Blood, 1990
- Multiple myeloma: significance of plasmablastic subtype in morphological classificationBlood, 1985
- A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survivalCancer, 1975